A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy



Status:Completed
Conditions:Colorectal Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:September 2007
End Date:December 2008
Contact:Jeffrey K Lee, B.A.
Email:jklee@ucsd.edu
Phone:510-847-1198

Use our guide to learn which trials are right for you!

The purpose of our study is to evaluate the diagnostic validity of a new immunofecal occult
blood test (IFOBT) (Teco Diagnostics) in U.S. veterans and to compare it with the guaiac
based FOBT.

Colorectal cancer (CRC) is the third most common cancer in men and women in the United
States with an estimated 147,000 new cases and more than 56,000 deaths each year. Early
detection of colon cancer and removal of precancerous adenomatous polyps have been shown to
reduce its morbidity, mortality and incidence. There are several recommended CRC screening
tests, including fecal occult blood test (FOBT), flexible sigmoidoscopy, air-contrast barium
enema, and colonoscopy. In the VA, FOBT is the predominant screening test for CRC. Numerous
randomized controlled trials have established the efficacy of FOBT in CRC screening. Its
advantages include privacy, noninvasiveness, and cost-effectiveness. Use of guaiac-based
testing, however, is hampered by low patient compliance, sensitivity, specificity, and
positive predictive value. The poor patient compliance, and low specificity and positive
predictive value, may be related to the testing procedure. For example, dietary and
medication restrictions are recommended to decrease false-negative and false-positive tests.
Such restrictions may impede patient compliance. Recently, several studies have evaluated
the effectiveness immunochemical-based testing as a potential alternative, with reportedly
better compliance, sensitivity, and specificity than guaiac-based tests. The purpose of our
study is to evaluate the diagnostic validity of a new IFOBT (Teco Diagnostics) in U.S.
veterans and to compare it with the guaiac based FOBT.

Inclusion Criteria:

- Patients (men or women) that are >18 years of age undergoing colonoscopy for a
variety of indications (bleeding, diarrhea, weight loss, anemia, abdominal pain, etc)

Exclusion Criteria:

- concurrent hospitalization

- visible rectal bleeding

- known diagnosis of inflammatory bowel disease

- hematuria

- menstruation at the time of obtaining a stool specimen and performing the tests

- inability to prepare the 3 different IFOBT or 3 different FOBT kits
We found this trial at
1
site
San Diego, California 92161
?
mi
from
San Diego, CA
Click here to add this to my saved trials